PRAXSYN CORP

As of September 30, 2015, PRAXSYN CORP carries a market capitalization of 10.78M, placing it among publicly traded companies globally. Its enterprise value stands at 13.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2015, PRAXSYN CORP has 633.92M shares outstanding.

As of September 30, 2015, PRAXSYN CORP trades at a trailing price-to-earnings ratio of 1.36. The price-to-sales ratio is 0.15, and the price-to-book ratio stands at 1.26.

As of September 30, 2015, PRAXSYN CORP trades at an EV/EBITDA multiple of 0.66 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.22 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 0.66 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 13.70M versus a market cap of 10.78M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2015, PRAXSYN CORP maintains a current ratio of 0.43, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.68, indicating elevated leverage, while an interest coverage ratio of 2.20 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2015, PRAXSYN CORP posted a return on equity (ROE) of 159.90, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 106.90 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 25.40, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 157.29, useful for judging operating efficiency across full business cycles. The company generates approximately 846,607.93 in revenue per employee across its workforce of 75.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.70 indicates how many times PRAXSYN CORP sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2015, PRAXSYN CORP recorded 5.30M in income tax expense. That works out to an effective tax rate of 43.42, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 12.22M, leaving 6.91M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended September 30, 2015, PRAXSYN CORP generated 63.50M in revenue and converted that into 6.91M in net income, yielding earnings per share of 0.01. EBITDA reached 20.72M, while operating income came in at 20.67M.

As of September 30, 2015, PRAXSYN CORP holds 654,252.00 in cash and equivalents against 3.57M in total debt, resulting in a net debt position of 2.92M. Total book value stands at 8.58M, with working capital of -16.54M providing operational flexibility.

PRAXSYN CORP produced -10.81M in operating cash flow over the twelve months ended September 30, 2015. After subtracting -158,656.00 in capital expenditures, free cash flow totaled -10.97M - equivalent to -0.02 per share.

Over the twelve months ended September 30, 2015, PRAXSYN CORP posted a gross margin of 88.62, reflecting its pricing power and cost economics. The operating margin of 32.55 and net profit margin of 10.89 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2015. Free cash flow yield is negative at -54.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -103.53, meaning PRAXSYN CORP raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2015, PRAXSYN CORP has an Altman Z-Score of 1.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.